Prevalence of Gene Rearrangement by Multiplex PCR in De Novo Acute Myeloid Leukemia in Adult Iraqi Patients

References

• Yu J, Li Y, Zhang D, Wan D, Jiang Z. Clinical implications of recurrent gene mutations in acute myeloid leukemia. Exp Hematol Oncol. 2020;9:4. doi:10.1186/s40164-020-00161-7
   PubMed Web of Science ®Google Scholar
• Hesham Moulod S, Ahmed AL-Rubaie H. April mRNA expression: does it predict the response to induction therapy in adult acute myeloid leukemia? Biochem Cell Arch. 2022;22:957–961.
   Google Scholar
• Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. J Am Soc Hematol. 2017;129(4):424–447.
   Google Scholar
• National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) Acute Myeloid Leukemia Version 2.2022. Plymouth Meeting (PA): NCCN; 2022.
   Google Scholar
• Tao S, Wang C, Chen Y, et al. Prognosis and outcome of patients with acute myeloid leukemia based on FLT3 ITD mutation with or without additional abnormal cytogenetics. Oncol Lett. 2019;18(6):6766–6774. doi:10.3892/ol.2019.11051
   PubMed Web of Science ®Google Scholar
• Pourrajab F, Zare-Khormizi MR, Hashemi AS, Hekmatimoghaddam S. Genetic characterization and risk stratification of acute myeloid leukemia. Cancer Manag Res. 2020;12:2231. doi:10.2147/CMAR.S242479
   PubMed Web of Science ®Google Scholar
• Gupta M, Mahapatra M, Saxena R. Cytogenetics’ impact on the prognosis of acute myeloid leukemia. J Lab Physicians. 2019;11(02):133–137. doi:10.4103/JLP.JLP_164_18
   PubMedGoogle Scholar
• AL-Saidi DN, Hameed BM, Khaleel KJ. Detection of RUNX1-RUNX1T1 fusion gene in AML patients by FISH technique in Iraq. J Commun Dis. 2021;53(4):54–60.
   Google Scholar
• Issa GC, Zarka J, Sasaki K, et al. Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements. Blood Cancer J. 2021;11(9):1. doi:10.1038/s41408-021-00557-6
   PubMed Web of Science ®Google Scholar
• Cox MC, Panetta P, Lo-Coco F, et al. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. Am J Clin Pathol. 2004;122(2):298–306. doi:10.1309/RX27R8GJQM330C22
   PubMed Web of Science ®Google Scholar
• Chen Y, Kantarjian H, Pierce S, et al. Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation. Leukemia. 2013;27(4):836–842. doi:10.1038/leu.2012.319
   PubMed Web of Science ®Google Scholar
• Bhatnagar B, Blachly JS, Kohlschmidt J, et al. Clinical features and gene-and microRNA-expression patterns in adult acute leukemia patients with t (11; 19)(q23; p13. 1) and t (11; 19)(q23; p13. 3). Leukemia. 2016;30(7):1586–1589. doi:10.1038/leu.2015.345
   PubMed Web of Science ®Google Scholar
• Liquori A, Ibañez M, Sargas C, Má S, Barragán E, Cervera J. Acute promyelocytic leukemia: a constellation of molecular events around a single PML-RARA fusion gene. Cancers. 2020;12(3):624. doi:10.3390/cancers12030624
   PubMed Web of Science ®Google Scholar
• Wen L, Xu Y, Yao L, et al. Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions. Haematologica. 2019;104(5):e195. doi:10.3324/haematol.2018.205369
   PubMed Web of Science ®Google Scholar
• Pulikkan JA, Castilla LH. Preleukemia and leukemia-initiating cell activity in inv (16) acute myeloid leukemia. Front Oncol. 2018;8:129. doi:10.3389/fonc.2018.00129
   PubMed Web of Science ®Google Scholar
• Herold T, Rothenberg-Thurley M, Grunwald VV, et al. Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia. Leukemia. 2020;34(12):3161–3172. doi:10.1038/s41375-020-0806-0
   PubMed Web of Science ®Google Scholar
• Acharya UH, Halpern AB, Wu QV, et al. Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML). J Drug Assess. 2018;7:51–53. doi:10.1080/21556660.2018.1492925
   PubMed Web of Science ®Google Scholar
• Tallman MS, Wang ES, Altman JK, et al. Acute myeloid leukemia, Version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:721–749. doi:10.6004/jnccn.2019.0028
   PubMed Web of Science ®Google Scholar
• Prassek VV, Rothenberg-Thurley M, Sauerland MC, et al. Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older. Haematologica. 2018;103:1853–1861. doi:10.3324/haematol.2018.191536
   PubMed Web of Science ®Google Scholar
• Rao AV. Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction. Hematology Am Soc Hematol Educ Program. 2016;2016(1):339–347.
   PubMed Web of Science ®Google Scholar
• AL-Khalissi KA. Experience with treatment of fifty eight Iraqi patients with Acute Myeloid Leukemia. JFacMedBagdad. 2014;55(4):290–295. doi:10.32007/jfacmedbagdad.554566
   Google Scholar
• Borthakur G, Kantarjian H. Core binding factor acute myelogenous leukemia-2021 treatment algorithm. Blood Cancer J. 2021;11(6):1–5. doi:10.1038/s41408-021-00503-6
   PubMed Web of Science ®Google Scholar
• Ustun C, Morgan E, Moodie EE, et al. Core‐binding factor acute myeloid leukemia with t (8; 21): risk factors and a novel scoring system (I‐CBF it). Cancer Med. 2018;7(9):4447–4455. doi:10.1002/cam4.1733
   PubMed Web of Science ®Google Scholar
• Hussein AG, Ali MS, Hassan MS, Mansoor SS, Ameri AM AL, Muhsin RJ. Haematologic parameters in acute promyelocytic leukemia patients treated with ALL trans- retinoic acid. J Fac Med Bagdad. 2007;49(1):51–55.
   Google Scholar
• Bill M, Mrózek K, Kohlschmidt J, et al. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A. Proceed National Acad Sci. 2020;117(42):26340–26346. doi:10.1073/pnas.2014732117
   PubMed Web of Science ®Google Scholar